By Thomas Anderson, Rotem Petranker — 2018
We just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very promising results.
Read on theconversation.com
CLEAR ALL
Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.
2
Amazonian healing traditions collide with Western medical sensibilities.
Consuming crumb-size amounts of psychedelics — not to get high but to feel more focused and creative and present — has moved a tiny bit mainstream.
3
It seems that psychedelics do more than simply alter perception. According to the latest research from my colleagues and me, they change the structures of neurons themselves.
1
Encounters with inter-dimensional beings, atheists discovering belief, and the bizarre world of DMT-induced entities. A trip to the fringes of psychedelic science.
The powerful hallucinogenic brew provokes long-lasting changes in two important brain networks.
Science is finally catching up with the potential powers of this psychedelic drink.
Using pharmacokinetic modeling and DMT blood sampling data, we demonstrate that the unique pharmacological characteristics of DMT, which also include a rapid onset and lack of acute tolerance to its subjective effects, make it amenable to administration by target-controlled intravenous infusion.
Taken together, our results suggest that psychedelic microdosing may alleviate symptoms of mood and anxiety disorders, though the potential hazards of this practice warrant further investigation.
These results support a recent model proposing that psychedelics reduce the ‘precision-weighting of priors’, thus altering the balance of top-down versus bottom-up information passing.